537 related articles for article (PubMed ID: 24196373)
1. Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency.
Luxembourg B; Pavlova A; Geisen C; Spannagl M; Bergmann F; Krause M; Alesci S; Seifried E; Lindhoff-Last E
Thromb Haemost; 2014 Feb; 111(2):249-57. PubMed ID: 24196373
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency.
Alhenc-Gelas M; Plu-Bureau G; Hugon-Rodin J; Picard V; Horellou MH;
Thromb Haemost; 2017 Jun; 117(6):1040-1051. PubMed ID: 28300866
[TBL] [Abstract][Full Text] [Related]
3. Novel SERPINC1 missense mutation (Cys462Tyr) causes disruption of the 279Cys-462Cys disulfide bond and leads to type Ⅰ hereditary antithrombin deficiency.
Zhang F; Gui Y; Lu Y; Liu D; Chen H; Qin X; Li S
Clin Biochem; 2020 Nov; 85():38-42. PubMed ID: 32745482
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis and thrombotic manifestations of antithrombin deficiency in 15 unrelated Chinese patients.
Ding Q; Wang M; Xu G; Ye X; Xi X; Yu T; Wang X; Wang H
Thromb Res; 2013 Sep; 132(3):367-73. PubMed ID: 23932013
[TBL] [Abstract][Full Text] [Related]
5. Antithrombin heparin binding site deficiency: A challenging diagnosis of a not so benign thrombophilia.
Orlando C; Heylen O; Lissens W; Jochmans K
Thromb Res; 2015 Jun; 135(6):1179-85. PubMed ID: 25837307
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin deficiency in three Japanese families: one novel and two reported point mutations in the antithrombin gene.
Maruyama K; Morishita E; Karato M; Kadono T; Sekiya A; Goto Y; Sato T; Nomoto H; Omi W; Tsuzura S; Imai H; Asakura H; Ohtake S; Nakao S
Thromb Res; 2013 Aug; 132(2):e118-23. PubMed ID: 23809926
[TBL] [Abstract][Full Text] [Related]
7. Subtypes of SERPINC1 mutations and the thrombotic phenotype of inherited antithrombin deficient individuals in Chinese Han population.
Wang D; Cui G; Hu S; Wang DW
Blood Cells Mol Dis; 2016 Nov; 62():38-41. PubMed ID: 27863268
[TBL] [Abstract][Full Text] [Related]
8. Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S.
Campello E; Spiezia L; Radu CM; Bulato C; Gavasso S; Tormene D; Woodhams B; Dalla Valle F; Simioni P
Thromb Haemost; 2016 Jan; 115(1):81-8. PubMed ID: 26354831
[TBL] [Abstract][Full Text] [Related]
9. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update.
Rodgers GM
Thromb Haemost; 2009 May; 101(5):806-12. PubMed ID: 19404531
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of antithrombin deficiency.
Luxembourg B; Delev D; Geisen C; Spannagl M; Krause M; Miesbach W; Heller C; Bergmann F; Schmeink U; Grossmann R; Lindhoff-Last E; Seifried E; Oldenburg J; Pavlova A
Thromb Haemost; 2011 Apr; 105(4):635-46. PubMed ID: 21264449
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hereditary antithrombin mutations is higher than estimated in patients with thrombotic events.
Fischer R; Sachs UJ; Heidinger KS; Eisenburger D; Kemkes-Matthes B
Blood Coagul Fibrinolysis; 2013 Jun; 24(4):444-8. PubMed ID: 23429250
[TBL] [Abstract][Full Text] [Related]
12. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary thromboembolism associated with hereditary antithrombin III deficiency: A case report.
Liu J; Wang Y; Rong C; Wang B; Liu X; Zhang W
Medicine (Baltimore); 2024 Mar; 103(10):e37429. PubMed ID: 38457560
[TBL] [Abstract][Full Text] [Related]
14. Regulatory regions of SERPINC1 gene: identification of the first mutation associated with antithrombin deficiency.
de la Morena-Barrio ME; Antón AI; Martínez-Martínez I; Padilla J; Miñano A; Navarro-Fernández J; Águila S; López MF; Fontcuberta J; Vicente V; Corral J
Thromb Haemost; 2012 Mar; 107(3):430-7. PubMed ID: 22234719
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of hereditary antithrombin-III deficiency in patients with a history of venous thromboembolism.
Vikydal R; Korninger C; Kyrle PA; Niessner H; Pabinger I; Thaler E; Lechner K
Thromb Haemost; 1985 Dec; 54(4):744-5. PubMed ID: 4089808
[TBL] [Abstract][Full Text] [Related]
16. Inherited antithrombin deficiency: a review.
Patnaik MM; Moll S
Haemophilia; 2008 Nov; 14(6):1229-39. PubMed ID: 19141163
[TBL] [Abstract][Full Text] [Related]
17. Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism.
Kuhle S; Lane DA; Jochmanns K; Male C; Quehenberger P; Lechner K; Pabinger I
Thromb Haemost; 2001 Oct; 86(4):1007-11. PubMed ID: 11686316
[TBL] [Abstract][Full Text] [Related]
18. Antithrombin deficiency and decreased protein C activity in a young man with venous thromboembolism: a case report.
Wang D; Tian M; Cui G; Wang DW
Front Med; 2018 Jun; 12(3):319-323. PubMed ID: 28861852
[TBL] [Abstract][Full Text] [Related]
19. c.1058C>T variant in the SERPINC1 gene is pathogenic for antithrombin deficiency.
Kumar R; Dawson JE; Chan AK; Forman-Kay JD; Kahr WH; Williams S
Br J Haematol; 2015 Jul; 170(1):123-5. PubMed ID: 25522812
[No Abstract] [Full Text] [Related]
20. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study.
Mahmoodi BK; Brouwer JL; Veeger NJ; van der Meer J
Circulation; 2008 Oct; 118(16):1659-67. PubMed ID: 18824642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
